SCHEMBL30458203

SCHEMBL30458203

COc1cc2ccnc(C)c2cc1OC

nearest known ligand 0.55

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CYP3A4 P08684 3/20 0.54
PDE10A Q9Y233 3/20 0.54
SMN1; SMN2 Q16637 3/20 0.54
ACHE P22303 3/20 0.54
USP2 O75604 2/20 0.54
ALDH1A1 P00352 2/20 0.54
LMNA P02545 2/20 0.54
CYP1A2 P05177 2/20 0.54
CYP2D6 P10635 2/20 0.54
CYP2C9 P11712 2/20 0.54
MAPK1 P28482 2/20 0.54
CYP2C19 P33261 2/20 0.54
PDE3B Q13370 2/20 0.54
PDE3A Q14432 2/20 0.54
HIF1A Q16665 2/20 0.54
RAB9A P51151 2/20 0.54
PDE2A O00408 1/20 0.54
ABCC4 O15439 1/20 0.54
PDE5A O76074 1/20 0.54
ABCB11 O95342 1/20 0.54

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3974591 1.00 CYP3A4 (0.54) CYP3A4PDE10ASMN1; SMN2ACHEUSP2
SCHEMBL17278085 0.89 MAPT (0.45) CYP3A4PDE10ASMN1; SMN2ACHEUSP2
SCHEMBL6640168 0.86 TNF (0.47) CYP3A4PDE10ASMN1; SMN2ACHEUSP2
SCHEMBL16431495 0.86 APAF1 (0.48) CYP3A4PDE10ASMN1; SMN2ACHEUSP2
SCHEMBL14538274 0.86 TRPA1 (0.54) CYP3A4PDE10ASMN1; SMN2ACHEUSP2
SCHEMBL16431829 0.86 APAF1 (0.48) CYP3A4PDE10ASMN1; SMN2ACHEUSP2
SCHEMBL15647963 0.79 TNF (0.59) CYP3A4PDE10ASMN1; SMN2ACHEUSP2
SCHEMBL20813447 0.79 CYP3A4 (0.53) CYP3A4PDE10ASMN1; SMN2ACHEUSP2
SCHEMBL5358941 0.79 TNF (0.57) CYP3A4PDE10ASMN1; SMN2ACHEUSP2
SCHEMBL15595899 0.79 SMN1; SMN2 (0.57) CYP3A4PDE10ASMN1; SMN2ACHEUSP2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2023055321-A1 ANTI-INFLAMMATORY MICROEMULSION EYE FORMULATIONS DERIVED FROM NIGELLA SATIVA OIL T.C. TRAKYA ÜNİVERSİTESİ (TR) 2023-04-06 WO disclosed